Neurology Minute
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
The Menopause Transition and Epilepsy
Dr. Katie Krulisky and Dr. Kelsey Smith discuss the impact of menopause on women with epilepsy, including therapeutics and clinical management during midlife.
Show citation:
Smith KM, Faubion SS, Vadlamudi L, et al. The Menopause Transition and Epilepsy: A Focus on Therapeutics. Neurol Clin Pract. 2026;16(5):e200650. doi:10.1212/CPJ.0000000000200650
The Menopause Transition and Epilepsy
Dr. Katie Krulisky and Dr. Kelsey Smith discuss the impact of menopause on women with epilepsy, including therapeutics and clinical management during midlife.
Show citation:
Smith KM, Faubion SS, Vadlamudi L, et al. The Menopause Transition and Epilepsy: A Focus on Therapeutics. Neurol Clin Pract. 2026;16(5):e200650. doi:10.1212/CPJ.0000000000200650
TRUE-MOGAD Score
Dr. Casey Kozak discusses a new scoring system for MOGAD identification.
Show citation:
Vilaseca A, Filippatou AG, Said Y, et al. TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results. Neurol Neuroimmunol Neuroinflamm. 2026;13(5):e200617. doi:10.1212/NXI.0000000000200617
Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers
Dr. Hailey Katulski discusses limb compression therapy and chemotherapy-induced peripheral neuropathy in women with gynecologic cancers.
Show citation:
Başkurt K, Uyar GC, Yeşilbaş E, et al. Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self-Controlled Study(NEURO-GLOVE Trial). Int J Cancer. 2026;159(9):2300-2313. doi:10.1002/ijc.70601
Delusional Misidentification Syndromes - Part 9
In the final episode of this nine-part series, Dr. Christine Cliatt-Brown discusses pharmacologic and non-pharmacologic management.
Herpes Zoster Vaccination and Incident Dementia in Canada
Dr. Margarita Fedorova and Dr. Pascal Geldsetzer discuss how the herpes zoster vaccination may have neuroprotective effects, potentially delaying or preventing dementia.
Show citation:
Pomirchy M, Chung S, Bommer C, Strobel S, Geldsetzer P. Herpes zoster vaccination and incident dementia in Canada: an analysis of natural experiments. Lancet Neurol. 2026;25(2):170-180. doi:10.1016/S1474-4422(25)00455-7
Understanding the Forces Shaping US Health Care
Dr. Jason Crowell and Dr. John McDonough discuss the historical and economic factors shaping the US healthcare system and why understanding these systemic forces matters for neurologists and patient care.
Show citation:
Powell A. How to fix U.S. Healthcare? "Radical Action," says John McDonough. Harvard Gazette. August 18, 2026. Accessed August 20, 2026. https://news.harvard.edu/gazette/story/2026/08/how-to-fix-u-s-healthcare-radical-action-says-john-mcdonough/.
Delusional Misidentification Syndromes - Part 8
In the eighth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses delusional companion syndrome.
Delusional Misidentification Syndromes - Part 7
In the seventh episode of this nine-part series, Dr. Christine Cliatt-Brown discusses reduplicative paramnesia.
Delusional Misidentification Syndromes - Part 6
In the sixth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses Cotard syndrome.
Prevalence of CTE at Death in National Football League Players
Dr. Shuvro Roy and Dr. Daniel Daneshvar discussed the prevalence of CTE at death among NFL players and the association between CTE severity and the risk of dementia.
Show citation:
Daneshvar DH, Nowinski CJ, Abdolmohammadi B, et al. Prevalence of chronic traumatic encephalopathy at death in National Football League players: retrospective population based cohort study, 2008-21. BMJ. 2026;394:e100418. Published 2026 Aug 25. doi:10.1136/bmj-2026-100418
Clinical Manifestations of Primary CNS T-Cell Lymphoma
Dr. Kait Nevel and Dr. Katharina Schmidbauer discuss primary CNS T-cell lymphoma, highlighting diagnostic challenges, imaging characteristics, and treatment approaches for this rare disease.
Show citation:
Schmidbauer KJ, Karschnia P, Kaulen LD, et al. Clinical Manifestations of Primary CNS T-Cell Lymphoma: A Retrospective Study of Histopathologic, Molecular, and Neuroimaging Features. Neurol. 2026;106(7):e214744. Published 2026 Mar 17. doi:10.1212/WNL.0000000000214744
October 2026 President Spotlight: One AAN Community
In the October episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss updates on membership options that will help more neurology professionals connect with the AAN.
Stay informed by watching the President's Spotlight video.
The Future of Child Neurology Residency Training - Part 2
In part two of this series, Dr. Dara Albert and Dr. Bruce Cohen highlight the most important takeaways from the task force findings.
Show citation:
Cohen BH, Gilbert DL, Xixis K, et al. Education Research: The Future of Child Neurology Residency Training: The Perspective of a Child Neurology Society Task Force. Neurol Educ. 2026;5(2):e200331. Published 2026 Jun 12. doi:10.1212/NE9.0000000000200331
Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations - Part 2
In the second episode of this two-part series, Dr. Tesha Monteith and Dr. Tamara Pringsheim discuss key take-home messages from the guideline recommendations and share insights on integrating them into clinical practice.
Show citation:
Potrebic S, Tanveer S, Becker WJ, et al. Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society. Headache. Published online August 31, 2026. doi:10.1111/head.70199
The Future of Child Neurology Residency Training - Part 1
In part one of this series, Dr. Dara Albert and Dr. Bruce Cohen discuss why the Child Neurology Society felt it was important to establish a task force to examine child neurology training at this point in time.
Show citation:
Cohen BH, Gilbert DL, Xixis K, et al. Education Research: The Future of Child Neurology Residency Training: The Perspective of a Child Neurology Society Task Force. Neurol Educ. 2026;5(2):e200331. Published 2026 Jun 12. doi:10.1212/NE9.0000000000200331
Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations - Part 1
In the first part of this two-part series, Dr. Tesha Monteith and Dr. Tamara Pringsheim provide a brief overview of the guideline recommendations for pharmacologic treatment of migraine prevention in adults.
Show citation:
Potrebic S, Tanveer S, Becker WJ, et al. Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society. Headache. Published online August 31, 2026. doi:10.1111/head.70199
Delusional Misidentification Syndromes - Part 5
In the fifth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses syndrome of subjective doubles.
Delusional Misidentification Syndromes - Part 4
In the fourth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses mirrored self-misidentification syndrome.
Delusional Misidentification Syndromes - Part 3
In the third episode of this nine-part series, Dr. Christine Cliatt-Brown discusses Fregoli syndrome.
Resolution of PML after Treatment with Virus-Specific T Cells and HCT
Dr. Justin Abbatemarco and Dr. Irene Cortese discuss recent advances in the treatment of progressive multifocal leukoencephalopathy (PML), focusing on immune-based therapies like virus-specific T cells and immune checkpoint inhibitors.
Show citation:
Gonzalez CE, Fletcher A, Jenkins TL, et al. Resolution of PML after Treatment with Virus-Specific T Cells and HCT. N Engl J Med. 2026;394(20):2061-2064. doi:10.1056/NEJMc2514186
Primary Motor Cortex Involvement and Seizure Risk in Patients With Brain Metastases
Dr. Kait Nevel and Drs. Ayal Aizer and Clara Baselga-Garriga discuss the link between primary motor cortex involvement in brain metastases and increased seizure risk.
Show citation:
Baselga-Garriga C, Purohit S, Lamba N, et al. Primary Motor Cortex Involvement and Its Association With Seizure Risk in Patients With Brain Metastases. Neurology. 2026;106(7):e214714. doi:10.1212/WNL.0000000000214714
Delusional Misidentification Syndromes - Part 2
In part two of this nine-part series, Dr. Christine Cliatt-Brown discusses Capgras syndrome.
Delusional Misidentification Syndromes - Part 1
In part one of this nine-part series, Dr. Christine Cliatt-Brown provides an overview of delusional misidentification syndromes.
Updates in Neuroinfectious Disease - Part 7
In the final episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the complex role of TNF alpha inhibition in tuberculosis treatment and the use of infliximab and other targeted therapies to manage inflammation.
September 7, 2026 Capitol Hill Report: BrainPAC
In this episode, Dr. Jose Posas reviews the Capitol Hill Report from September 7th, discussing the busy month ahead for Congress, BrainPAC, and a couple of other advocacy news items.
Stay updated with what's happening on the hill by visiting aan.com/chr.
Learn how you can get involved with AAN advocacy.
Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments - Part 2
In part two of this series, Dr. Aaron Zelikovich and Dr. Bhaskar Roy discuss recommendations to help neurologists navigate the expanding landscape of myasthenia gravis treatments.
Show citation:
McLaren NP, Rosati M, Zhong W, et al. Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments: A Bayesian Network Meta-Analysis. Neurology. 2026;107(3):e218351. doi:10.1212/WNL.0000000000218351
Bridging the Artificial Intelligence Training Gap - Part 2
In the second episode of this series, Dr. Justin Abbatemarco and Dr. Sara Marceglia discuss the risks of incorporating AI into clinical practice. Show citation: Vozzi C, Sibilla M, Sandri D, et al. Education Research: Bridging the Artificial Intelligence Training Gap: Evidence from a National Survey of Italian Neurology Residents. Neurol Educ. 2026;5(1):e200289. Published 2026 Jan 27. doi:10.1212/NE9.0000000000200289
Updates in Neuroinfectious Disease - Part 6
In the sixth episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss high-dose rifampin in TB meningitis.
Bridging the Artificial Intelligence Training Gap - Part 1
In part one of this series, Dr. Justin Abbatemarco and Dr. Alberto Priori discussed the use of artificial intelligence in neurology among peers, not just trainees. Show citation: Vozzi C, Sibilla M, Sandri D, et al. Education Research: Bridging the Artificial Intelligence Training Gap: Evidence from a National Survey of Italian Neurology Residents. Neurol Educ. 2026;5(1):e200289. Published 2026 Jan 27. doi:10.1212/NE9.0000000000200289
September 2026 President Spotlight: Our Next Step in Brain Health
In the September episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss BrainHealth.com and the AAN's expanding brain health movement.
Stay informed by watching the President's Spotlight video.
Updates in Neuroinfectious Disease - Part 5
In the fifth episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss dexamethasone and listeria meningitis.
Updates in Neuroinfectious Disease - Part 4In the third episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss HSV encephalitis and dexamethasone.
In the fourth episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the use of dexamethasone in the treatment of pneumococcal meningitis.
Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments - Part 1
In the first installment of this series, Dr. Aaron Zelikovich and Dr. Bhaskar Roy discuss how emerging treatments for myasthenia gravis compare to one another.
Show citation:
McLaren NP, Rosati M, Zhong W, et al. Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments: A Bayesian Network Meta-Analysis. Neurology. 2026;107(3):e218351. doi:10.1212/WNL.0000000000218351
National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care
Dr. Jason Crowell and Ka-Ho Wong discuss national trends in Medicare reimbursement for inpatient neurologic care.
Show citation:
Wong KH, Castillo M, King J, et al. National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care, 2013-2023. Neurology. 2026;107(6):e218460. doi:10.1212/WNL.0000000000218460
Updates in Neuroinfectious Disease - Part 3
In the third episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss HSV encephalitis and dexamethasone.
Updates in Neuroinfectious Disease - Part 2
In part two of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss pegivirus-associated encephalomyelitis.
Updates in Neuroinfectious Disease - Part 1
In part one of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss acute necrotizing encephalopathy.
2026 Alzheimer's Association International Conference - Part 1
In part one of this series, Drs. Greg Cooper, Trey Bateman, and Gregg Day discussed key takeaways from the 2026 Alzheimer's Association International Conference, focusing on blood-based biomarkers, anti-amyloid therapies, and other important highlights.
Recap from the 2026 AAN Autoimmune Neurology Conference
Dr. Justin Abbatemarco recaps a presentation on Hashimoto encephalopathy from the AAN Autoimmune Neurology Conference. Show citation: Valencia-Sanchez C, Pittock SJ, Mead-Harvey C, et al. Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis. Brain Commun. 2021;3(2):fcaa233. Published 2021 Jan 5. doi:10.1093/braincomms/fcaa233 Brain, Jellinek E, Ball K
HASHIMOTO'S DISEASE AND ENCEPHALOPATHY
The Lancet, 288, 512-514 Mattozzi S, Sabater L, Escudero D, et al. Hashimoto encephalopathy in the 21st century. Neurology. 2020;94(2):e217-e224. doi:10.1212/WNL.0000000000008785
